Control of apoptosis by p53FRIDMAN, Jordan S; LOWE, Scott W.Oncogene (Basingstoke). 2003, Vol 22, Num 56, pp 9030-9040, issn 0950-9232, 11 p., NS8Article

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsQUINTAS-CARDAMA, Alfonso; VADDI, Kris; RUPAR, Mark et al.Blood. 2010, Vol 115, Num 15, pp 3109-3117, issn 0006-4971, 9 p.Article

Sunrival signalling by Akt and EIF4E in oncogenesis and cancer therapyWENDEL, Hans-Guido; DE STANCHINA, Elisa; FRIDMAN, Jordan S et al.Nature (London). 2004, Vol 428, Num 6980, pp 332-337, issn 0028-0836, 6 p.Article

Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWENQING YAO; JINCONG ZHUO; MARANDO, Cindy A et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 1, pp 159-163, issn 0960-894X, 5 p.Article

Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancerWENQING YAO; JINCONG ZHUO; QIYAN LIN et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 4, pp 603-606, issn 0022-2623, 4 p.Article

Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancerFRIDMAN, Jordan S; CAULDER, Eian; GRANDIS, Jennifer R et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1892-1902, issn 1078-0432, 11 p.Article

Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionBURNS, David M; LI, Yun-Long; COVINGTON, Maryanne B et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 13, pp 3525-3530, issn 0960-894X, 6 p.Article

Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P'₁ permutationsBURNS, David M; CHUNHONG HE; FRIDMAN, Jordan S et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 2, pp 560-564, issn 0960-894X, 5 p.Article

Tumor promotion by Mdm2 splice variants unable to bind p53FRIDMAN, Jordan S; HERNANDO, Eva; HEMANN, Michael T et al.Cancer research (Baltimore). 2003, Vol 63, Num 18, pp 5703-5706, issn 0008-5472, 4 p.Article